Order Article Reprints

Heching M, Cohen-Kutner M, Ben-Zvi H, Slomianksy L, Chass Maurice E, Nur Maymon N, Mandel S, Oholy M, Moses R, Lavon M, et al. In Vitro Antimicrobial Activity of the Novel Antimicrobial Peptide OMN51 Against Multi-Drug-Resistant Pseudomonas aeruginosa Isolated from People with Cystic Fibrosis. Journal of Clinical Medicine. 2025; 14(15):5208. https://doi.org/10.3390/jcm14155208

Heching, Moshe, Moshe Cohen-Kutner, Haim Ben-Zvi, Liora Slomianksy, Elital Chass Maurice, Noa Nur Maymon, Shira Mandel, Michal Oholy, Rony Moses, Michal Lavon, and et al. 2025. "In Vitro Antimicrobial Activity of the Novel Antimicrobial Peptide OMN51 Against Multi-Drug-Resistant Pseudomonas aeruginosa Isolated from People with Cystic Fibrosis" Journal of Clinical Medicine 14, no. 15: 5208. https://doi.org/10.3390/jcm14155208

Heching, M., Cohen-Kutner, M., Ben-Zvi, H., Slomianksy, L., Chass Maurice, E., Nur Maymon, N., Mandel, S., Oholy, M., Moses, R., Lavon, M., Kaufman, K., Mayost Lev-Ari, O., Shachar, T., Weinberg, J., Kramer, M. R., & Bachnoff, N. (2025). In Vitro Antimicrobial Activity of the Novel Antimicrobial Peptide OMN51 Against Multi-Drug-Resistant Pseudomonas aeruginosa Isolated from People with Cystic Fibrosis. Journal of Clinical Medicine, 14(15), 5208. https://doi.org/10.3390/jcm14155208